Simplex Trading
NMRA icon

Simplex Trading’s Neumora Therapeutics NMRA Stock Holding History

Simplex Trading’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$87.2K Sell
51,300
-8,400
-14% -$16K ﹤0.01% 5724
2026
Q1 		$116K Buy
59,700
+34,500
+137% +$89.4K ﹤0.01% 4909
2025
Q4 		$45.1K Sell
25,200
-16,600
-40% -$36.3K ﹤0.01% 5742
2025
Q3 		$76K Buy
41,800
+4,000
+11% +$6.47K ﹤0.01% 6044
2025
Q2 		$27K Sell
37,800
-17,800
-32% -$13.5K ﹤0.01% 6498
2025
Q1 		$55K Sell
55,600
-90,500
-62% -$155K ﹤0.01% 5668
2024
Q4 		$1.55M Buy
146,100
+63,700
+77% +$763K ﹤0.01% 2419
2024
Q3 		$1.09M Buy
82,400
+82,000
+20,500% +$957K ﹤0.01% 2856
2024
Q2 		$3K Sell
400
-600
-60% -$6.21K ﹤0.01% 8136
2024
Q1 		$13K Sell
1,000
-500
-33% -$8.08K ﹤0.01% 7424
2023
Q4 		$25K Buy
+1,500
New +$18.4K ﹤0.01% 6740

Other funds holding NMRA

SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $3.47B AUM 23.76% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Simplex Trading's NMRA Position: Q2 2026 in Review

Simplex Trading increased its Neumora Therapeutics (NMRA) stake by 55% in Q2 2026, buying an estimated $135K and bringing the position to 199,810 shares worth $340K. The position accounts for ﹤0.01% of the portfolio, ranked #4081.

Simplex Trading first reported a position in NMRA in Q1 2024 and has held it in 7 quarters since. 113 funds tracked by Wall St. Rank hold NMRA as of Q2 2026.

  • Simplex Trading held 199,810 shares of Neumora Therapeutics worth $340K as of Q2 2026.
  • Simplex Trading bought 70,654 Neumora Therapeutics shares in Q2 2026, an estimated $135K.
  • Neumora Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #4081 holding.
  • Simplex Trading first reported a position in Neumora Therapeutics in Q1 2024 and has held it in 7 quarters since.
  • 113 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.